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ABSTRACT
Objective This study aimed to explore tobacco smoking
in seven major cities of Latin America.
Methods The Cardiovascular Risk Factor Multiple
Evaluation in Latin America (CARMELA) study is
a cross-sectional epidemiological study of 11550 adults
between 25 and 64 years old in Barquisimeto,
Venezuela; Bogota, Colombia; Buenos Aires, Argentina;
Lima, Peru; Mexico City, Mexico; Quito, Ecuador; and
Santiago, Chile. Tobacco smoking, including cigarettes,
cigars and pipes, was surveyed among other
cardiovascular risk factors.
Results Santiago and Buenos Aires had the highest
smoking prevalence (45.4% and 38.6%, respectively);
male and female rates were similar. In other cities, men
smoked more than women, most markedly in Quito
(49.4% of men vs 10.5% of women). Peak male smoking
prevalence occurred among the youngest two age
groups (25e34 and 35e44 years old). Men and women
of Buenos Aires smoked the highest number of
cigarettes per day on average (15.7 and 12.4,
respectively). Men initiated regular smoking earlier than
women in each city (ranges 13.7e20.0 years vs
14.2e21.1 years, respectively). Exposure to secondhand
tobacco smoke at workplace for more than 5 h per day
was higher in Barquisimeto (28.7%), Buenos Aires
(26.8%) and Santiago (21.5%). The highest prevalence of
former smokers was found among men in Buenos Aires,
Santiago and Lima (30.0%, 26.8% and 26.0%
respectively).
Conclusions Smoking prevalence was high in the seven
CARMELA cities, although patterns of smoking varied
among cities. A major health and economic burden is
inevitable in urban Latin America unless effective
comprehensive tobacco control measures recommended
by the World Health Organisation Framework Convention
on Tobacco Control are implemented.
Many developing countries are experiencing
a tobacco epidemic, portending increased burden of
chronic diseases. Well known as the main causal
factor for lung cancer, tobacco use also promotes
the development of vascular disease
1 and, thus, is
a risk factor for ischaemic and peripheral heart
disease and stroke.
2 Smoking is responsible for half
of all avoidable deaths worldwide,
3 and half of
those deaths occur during the stage of life that is
normally the most productive.
4 Currently, cardio-
vascular disease accounts for nearly half of
smoking-related deaths in developed nations and
more than a quarter in developing regions.
5
Smoking has been on the rise in developing regions,
and by 2030, it has been estimated that approxi-
mately 70% of the 10 million deaths attributed to
tobacco will occur in low- and middle-income
countries.
4
Epidemiological studies have conﬁrmed the
contribution of active smoking to cardiovascular
risk. In 2004, the INTERHEART Study reported an
odds ratio (OR) for acute myocardial infarction of
2.87 for current versus never smokers,
6 which is
similar to another study conducted in Latin
America in 1998 that found ORs of 2.50, 2.12
and 2.40 in Venezuela, Mexico and Argentina,
respectively.
7
Exposure to secondhand tobacco smoke (SHS)
has been found to increase the risk of cardiovas-
cular disease by approximately 30%, more so
than would be expected based on comparable
amounts of active exposure to tobacco smoke.
8 In
2003e2004, high levels of airborne nicotine were
found extensively in public places in several Latin
American cities, particularly in Argentina and
Uruguay.
9
Despite strong recommendations to eliminate
smoking to reduce cardiovascular disease,
10 the
World Health Organisation (WHO) estimates that
worldwide, the number of smokers is expected to
increase from 1.3 billion to 1.7 billion by the year
2025.
11
In 2005, the WHO Framework Convention on
Tobacco Control (FCTC), the ﬁrst global public
health treaty to adopt evidence-based measures
aimed at reducing tobacco consumption, became
into force.
12 While smoking has declined in high-
income countries after governmental tobacco
control policies were implemented, 82% of the
smokers live in low- and middle-income countries.
13
In Latin American countries, not enough infor-
mation has been available for local policymakers to
implement tobacco control measures in accordance
with speciﬁc cultural and economic milieus.
4 14 We
were not able to ﬁnd in the peer-reviewed literature
smoking prevalence studies among adults in Latin
America using a standardised and comparable
methodology. In 2007, and as a component of the
WHO/Centers for Disease Control and Prevention
Global Tobacco Surveillance System, the Global
Adult Tobacco Survey was launched to systemati-
cally collect data on tobacco use among adults
comparable across countries. Data from Brazil,
Mexico and Uruguay was gathered In Latin
America. However, no results have been published
as of December 2009. The Cardiovascular Risk
Factor Multiple Evaluation in Latin America
(CARMELA) Study explored the prevalence of
cardiovascular risk factors, including the assess-
ment of smoking and SHS exposure, in seven major
cities of Latin America. An initial report from the
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Research paperentire CARMELA Study has previously been published.
15 The
ﬁndings related to prevalence and associations of smoking are
reported here.
METHODS
Study design
CARMELA is a multistage, cross-sectional epidemiological study
conducted between September 2003 and August 2005 in
Barquisimeto, Venezuela; Bogota, Colombia; Buenos Aires,
Argentina; Lima, Peru; Mexico City, Mexico; Quito, Ecuador;
and Santiago, Chile. The study was approved by local human
research ethics committees in each country.
Sampling
A total of 11550 participants (approximately 1600 participants
per city) between the ages of 25 and 64 years were included,
stratiﬁed by sex and four 10-year age groups (25e34, 35e44,
45e54 and 55e64). This number was selected on the basis of the
sample sizes in similar studies, expected variation in risk factors
and limitations dictated by study resources. Cities were ﬁrst
divided into geographic sectors and then into primary sampling
units (city blocks or other appropriate areas), which were
randomly selected for further sampling. Households present in
selected primary sampling units were placed into four categories,
and then a systematic sample was obtained within each cate-
gory. In category 1, all eligible and consenting residents aged
25e64 years were interviewed; in category 2, only residents
aged 35e64 years were interviewed; in category 3, only residents
aged 45e64 years were interviewed; and in category 4, only
residents aged 55e64 years were interviewed. The sampling
fraction in each category was determined so that an equal
probability sampling was obtained within each sexeage group.
This strategy was conceived to minimise the number of
households to be visited, taking into account that group sizes
decrease with age. Sampling was also adjusted on the basis of
non-response rates from a pilot study of 50 enrollees per city.
Each city resident between the ages of 25 and 64 years (and
ultimately everyone in each deﬁned age group) had a prede-
termined non-zero probability of selection. Anyone within the
age limits residing at selected addresses was eligible for inclusion;
subjects were included only if they completed the survey and
clinical visit. Exclusion criteria comprised persons residing at
addresses that were not households or were in marginal areas
considered to endanger interviewers and persons visiting at the
selected addresses. Interviewers, trained and certiﬁed by
CARMELA investigators, administered a questionnaire custom-
ised from well-known cardiovascular epidemiological question-
naires (WHO STEPwise approach to surveillance and the US
Behavioural Risk Factor Surveillance System) to collect infor-
mation on demographics, hypertension, hypercholesterolemia,
diabetes and smoking. More details on the study design are
described elsewhere.
15
Deﬁnitions
Current smokers are those individuals who have smoked 100
cigarettes, 20 cigars or 20 pipes in their lifetime daily or occa-
sionally and who currently smokes cigarettes, cigars or pipes.
Former smokers are those who have smoked at least 100 ciga-
rettes, 20 cigars or 20 pipes in their lifetimes but who had
not smoked in the past 12 months. Never smokers are those
who have never smoked or who have smoked <100 cigarettes,
20 cigars or 20 pipes in their lifetime.
Statistical analysis
Statistical processing addressed the non-equal probability char-
acter of the sample and the structure of the design to generate
data adjusted for the age and gender distribution of the popu-
lation of each city. Means and prevalence along with their 95%
conﬁdence intervals were estimated by survey analysis proce-
dures (SAS Software, Release 9.1), taking into account the
multistage stratiﬁed sampling design via CLUSTER and
STRATA statements.
RESULTS
CARMELA surveyed a total of 11550 participants: 1848
(Barquisimeto), 1553 (Bogota), 1482 (Buenos Aires), 1652
(Lima), 1722 (Mexico City), 1638 (Quito) and 1655 (Santiago).
Demographics
Table 1 shows demographic characteristics of the sample in each
of the seven cities. In this study, participants from Buenos Aires
had the highest level of formal education, and those from
Barquisimeto had the lowest. In all seven cities, overall, men had
higher level of education than women. The age group
25e34 years had the highest level of education in almost all
seven cities, and the age group 55e64 years had the lowest.
Table 1 Demographics: education level* (mean) (95% CI) by city, sex and age group
Barquisimeto
(n[1848)
Bogota
(n[1553)
Buenos Aires
(n[1482)
Lima
(n[1652)
Mexico city
(n[1722)
Quito
(n[1638)
Santiago
(n[1655)
Overall 9.0 (8.6e9.3) 9.2 (8.8e9.6) 13.9 (13.5e14.2) 12.9 (12.7e13.2) 12.1 (11.8e12.4) 10.5 (9.9e11.1) 11.7 (11.3e12.0)
M 9.1 (8.7e9.4) 9.5 (9.0e10.0) 14.0 (13.6e14.4) 13.5 (13.2e13.9) 13.1 (12.7e13.5) 11.3 (10.6e11.9) 12.1 (11.7e12.5)
W 8.9 (8.5e9.3) 8.9 (8.5e9.4) 13.8 (13.3e14.2) 12.4 (12.0e12.7) 11.2 (10.9e11.5) 9.7 (9.1e10.3) 11.3 (10.9e11.6)
25e34 years
M 10.0 (9.5e10.6) 10.6 (9.9e11.3) 14.5 (13.9e15.1) 13.6 (13.2e14.0) 14.2 (13.6e14.8) 12.0 (10.9e13.0) 13.0 (12.4e13.6)
W 10.2 (9.6e10.8) 10.3 (9.7e10.9) 14.5 (14.0e15.0) 13.0 (12.5e13.4) 12.7 (12.1e13.2) 10.9 (10.0e11.8) 12.4 (12.0e12.8)
35e44 years
M 8.5 (7.9e9.2) 9.1 (8.5e9.7) 14.2 (13.5e14.8) 13.8 (13.4e14.3) 12.8 (12.3e13.4) 11.7 (10.8e12.6) 12.4 (11.9e12.9)
W 9.0 (8.4e9.6) 9.0 (8.5e9.6) 14.5 (13.8e15.2) 12.4 (11.8e13.0) 11.5 (11.0e12.0) 10.1 (9.2e11.0.) 11.5 (10.9e12.0)
45e54 years
M 8.8 (8.2e9.4) 9.3 (8.5e10.1) 14.0 (13.2e14.8) 13.3 (12.7e13.9) 12.0 (11.4e12.6) 10.3 (9.5e11.1) 11.4 (10.9e12.0)
W 7.7 (7.3e8.2) 8.1 (7.4e8.8) 13.9 (13.1e14.7) 12.0 (11.5e12.5) 10.0 (9.4e10.5) 8.4 (7.8e9.1) 10.5 (10.0e11.1)
55e64 years
M 6.9 (6.3e7.5) 7.5 (6.8e8.2) 12.8 (12.2e13.4) 13.2 (12.6e13.9) 11.4 (10.4e12.4) 9.4 (8.4e10.4) 10.3 (9.7e10.8)
W 6.6 (6.0e7.2) 6.0 (5.4e6.6) 11.7 (11.0e12.5) 11.1 (10.6e11.7) 8.2 (7.7e8.7) 6.8 (6.2e7.4) 9.6 (9.0e10.1)
95% CI, 95% conﬁdence interval.
*Education level as completed years of formal education.
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Table 2 shows current smoking prevalence by city, sex and age
group. In this study, overall smoking prevalence ranged from
21.8% (in Barquisimeto) to 45.4% (in Santiago) across all seven
CARMELA cities. The highest male smoking prevalences were
found in Santiago and Quito (47.7% and 49.4%, respectively),
while the highest female smoking prevalences were found in
Santiago and Buenos Aires (43.3% and 37.7%, respectively).
Among men, smoking was most frequent in the youngest two
age groups (25e34 and 35e44 years old) and declined with
successive age groups. Female smoking prevalence was lowest in
the oldest age range of each city. Quito had the highest male
smoking prevalence and the lowest female smoking prevalence
in all age groups studied. Men of Bogota and Lima of all age
ranges had approximately twice the smoking prevalence as did
women of the same age, while men and women of Buenos Aires
and Santiago had similar smoking prevalence.
Table 3 shows the smoking status by city and sex. Never
smokers were consistently higher among women than men in
all studied cities, with Quito and Santiago having the highest
and the lowest never smoking prevalence (83.9% and 39.4%
respectively).
Age of smoking initiation
In our study, smoking initiation occurred among the youngest in
Santiago (15.1 years) and the oldest in Mexico City (22.6 years).
These data are not consistent with other research studies
previously published, and the differences may be the result of
the age interval of our sample (25e64 years). Men initiated
regular smoking earlier than women of each city (ranges,
13.7e20.0 vs 14.2e21.1 years, respectively).
Daily number of cigarettes
Figure 1 shows the mean daily consumption of cigarettes by sex
and city. Of those daily smokers who have smoked within the
month before the survey, those in Mexico City smoked the
smallest number of cigarettes per day on average (5.5), while
those in Buenos Aires smoked the largest (13.9). In all cities, men
smoked more cigarettes per day than women, with the largest
difference in Barquisimeto and Buenos Aires. In Santiago, a city
with relatively high and similar male and female smoking
prevalence, a nearly equivalent number of cigarettes were
smoked per day (8.0 and 7.9, respectively).
Quit attempts
In the 12 months before the study, 65.4% and 52.6% of smokers
in Mexico City and Lima, respectively, tried to quit smoking,
while <40% of smokers in other cities tried to quit. Of those
smokers who ever attempted to quit, mean number of life
attempts ranged from 2.5 (Bogotá) to 3.9 (Lima). In all cities,
greater numbers of smokers had quit in the last 1e5 years than
within the 5e10 years before the study.
Secondhand tobacco smoke exposure
Extensive exposure to SHS in the workplace (>5 h/day) was
reported by approximately 25% of participants in Barquisimeto,
Table 2 Current smoking* prevalence (%) (95% CI) by city, sex and age group
Barquisimeto
(n[1848)
Bogota
(n[1553)
Buenos Aires
(n[1482)
Lima
(n[1652)
Mexico City
(n[1722)
Quito
(n[1638)
Santiago
(n[1655)
Overall 21.8 (19.3e24.2) 22.2 (19.1e25.2) 38.6 (36.0e41.2) 26.6 (23.9e29.4) 27.3 (25.0e29.5) 29.9 (27.0e32.7) 45.4 (42.8e47.9)
M 32.2 (27.7e36.7) 31.3 (27.1e35.5) 39.7 (36.2e43.2) 38.0 (34.2e41.7) 34.4 (30.2e38.5) 49.4 (45.9e52.9) 47.7 (44.2e51.1)
W 14.9 (12.7e17.1) 15.0 (11.1e18.9) 37.7 (34.2e41.3) 15.4 (12.6e18.2) 21.0 (18.8e23.2) 10.5 (7.8e13.2) 43.3 (39.7e46.9)
25e34 years
M 39.9 (31.1e48.7) 28.4 (21.6e35.2) 40.2 (33.7e46.7) 40.2 (33.8e46.6) 36.7 (30.2e43.3) 51.3 (44.2e58.4) 50.5 (43.5e57.6)
W 8.9 (5.2e12.6) 13.2 (7.4e18.9) 38.8 (32.8e44.9) 16.3 (10.8e21.9) 20.2 (14.5e25.9) 9.5 (5.5e13.5) 50.5 (43.1e57.9)
35e44 years
M 29.0 (21.7e36.3) 40.2 (33.7e46.7) 40.2 (33.7e46.7) 40.2 (31.8e48.6) 36.8 (29.4e44.2) 51.4 (44.8e57.9) 55.5 (49.2e61.8)
W 22.9 (18.2e27.6) 18.8 (12.1e25.4) 39.4 (33.5e45.2) 15.7 (10.9e20.5) 24.5 (19.2e29.9) 12.2 (7.1e17.2) 41.7 (35.5e47.8)
45e54 years
M 25.9 (18.6e33.3) 27.5 (20.1e34.9) 35.5 (27.7e43.3) 36.9 (30.1e43.7) 29.8 (22.2e37.3) 46.5 (39.0e54.1) 42.2 (35.5e48.8)
W 15.3 (11.3e19.3) 14.7 (9.7e19.6) 41.2 (33.2e49.2) 17.4 (12.7e22.1) 21.5 (17.2e25.8) 12.4 (7.9e16.8) 46.0 (38.6e53.3)
55e64 years
M 22.1 (15.2e29.0) 24.5 (18.5e30.5) 30.9 (23.7e38.1) 29.6 (22.7e36.5) 28.1 (21.5e34.7) 43.0 (34.9e51.1) 32.0 (26.4e37.6)
W 9.4 (6.1e12.7) 10.5 (5.6e15.4) 28.1 (20.9e35.4) 9.8 (5.8e13.8) 14.6 (10.4e18.9) 6.2 (2.8e9.5) 28.1 (21.6e34.7)
95% CI, 95% conﬁdence interval.
*Current smoking is deﬁned as daily or occasional smoking of cigarettes, cigars or pipes.
Table 3 Smoking status prevalence (%) (95% CI) by city and sex
Barquisimeto Bogota Buenos Aires Lima Mexico city Quito Santiago
Men
Current* 32.2 (27.7e36.7) 31.3 (27.1e35.5) 39.7 (36.2e43.2) 38.0 (34.2e41.7) 34.4 (30.2e38.5) 49.4 (45.9e52.9) 47.7 (44.2e51.1)
Formery 22.3 (19.2e25.3) 18.9 (15.2e22.5) 30.0 (26.9e33.1) 26.0 (22.6e29.4) 14.8 (12.1e17.6) 18.0 (15.5e20.5) 26.8 (23.6e30.1)
Neverz 45.5 (40.8e50.3) 49.8 (45.3e54.4) 30.4 (26.6e34.1) 36.0 (31.9e40.2) 50.8 (45.9e55.7) 32.6 (29.4e35.7) 25.5 (22.4e28.6)
Women
Current* 14.9 (12.7e17.1) 15.0 (11.1e18.9) 37.7 (34.2e41.3) 15.4 (12.6e18.2) 21.0 (18.8e23.2) 10.5 (7.8e13.2) 43.3 (39.7e46.9)
Formery 12.8 (10.9e14.7) 8.5 (6.4e10.7) 23.1 (18.0e24.5) 21.8 (18.4e25.2) 8.9 (6.7e11.1) 5.6 (3.7e7.6) 17.3 (14.9e19.8)
Neverz 72.3 (69.5e75.1) 76.5 (72.7e80.3) 41.0 (37.2e44.7) 62.8 (58.7e66.8) 70.1 (67.3e73.0) 83.9 (80.0e87.8) 39.4 (36.1e42.7)
95% CI, 95% conﬁdence interval.
*Participants who reported daily or occasional consumption of cigarettes, cigars or pipe tobacco.
yParticipants who had smoked at least 100 cigarettes, 10 cigars or 10 pipes in their lifetime but who have quit smoking a year ago.
zParticipants who never smoked or smoked <100 cigarettes, 20 cigars or 20 pipes in their lifetime.
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Research paperBuenos Aires and Santiago, but was much less common in
Bogota, Lima, Mexico City and Quito (8.6%, 5.0%, 14.5% and
3.9%, respectively). Among participants living with at least one
smoker, Quito and Santiago had the highest percentage
reporting that smoking was not allowed at home (43.3% and
44.9%, respectively), while Barquisimeto and Buenos Aires had
the lowest (13.4% and 13.5%, respectively).
DISCUSSION
The CARMELA Study revealed large differences in smoking
prevalence in urban Latin America. In this study, the highest
overall smoking prevalences were found in Buenos Aires and
Santiagowithnogenderdifferences.Incontrast,inallothercities,
smoking prevalence in men was higher than in women, reaching
in Quito nearly ﬁve times more. Peak smoking prevalence was
found among younger participants. Men initiated smoking at
earlier ages than women. Smokers in Buenos Aires smoked the
mostnumberofcigarettesperday,andinallcitiesexceptSantiago,
men smoked more cigarettes than women per day. Participants
reported a high exposure to SHS both at work and at home.
It has been estimated that worldwide, 29% of the population
aged 15 years and older smoke tobacco, with highest overall
rates in Europe and Central Asia (35%). Globally, men smoke
more than women (47% vs 11%, respectively), and prevalence of
daily smoking peaks at ages 30e49 years (36e37%).
13 Although
variable by country, adult smoking prevalence in Latin America
has been reported to be approximately 40% for men and 24% for
women, with 32% prevalence overall.
4 A 2008 WHO report
published adjusted prevalence estimates that are lower than
previously reported.
16 The results of the CARMELA Study bear
out these estimates. In general, men smoked more than women,
and in total, 30.2% of CARMELA Study participants reported
current smoking. Overall number of cigarettes consumed daily
on average in CARMELA cities was relatively low, except in
Buenos Aires. Although age-group overlap might preclude
adequate comparisons, the highest smoking prevalence in all
CARMELA cities was found in younger age groups than
worldwide estimates suggest.
Between 1989 and 1992, various studies show that 35e41% of
men and 13e19% of women of Peru, Argentina, Mexico, Chile
and Colombia were smokers.
17 Over a decade later, the
CARMELA Study seems to indicate that more women are
smoking in Lima, Buenos Aires, Mexico City and Santiago,
markedly so in Santiago and Buenos Aires, cities that now have
similar prevalence in both genders. One possible explanation for
the apparent increase in tobacco consumption among women
would be the tobacco companies’ marketing strategies targeting
young women.
18 However, caution is necessary in comparing
these results, given the entirely urban population of CARMELA
and the cross-sectional nature of both studies. More recently,
WHO reported a higher smoking prevalence among women of
Venezuela, Colombia, Mexico and Ecuador and a lower preva-
lence of both genders in Chile than in corresponding CARMELA
cities.
16 Nonetheless, the WHO data generally include younger
participants (lower limit, 15e18 years of age) and have less
standardised methods than the CARMELA Study. Both results
from the CARMELA Study and WHO may underestimate true
smoking prevalence, as data collected were self-reported and
lacked objective validation with, for example, urine cotinine
levels.
19
The stages of the tobacco epidemic model described by Lopez
et al
3 may be used to describe differences among CARMELA
cities. This model was developed as a descriptive tool for
Western developed countries and, as such, may not be entirely
applicable to Latin America. Furthermore, whether the lung
cancer epidemic is as consistently reﬂective for women has been
questioned recently.
20 Nevertheless, with the additional caveat
that CARMELA is a cross-sectional study carried out over
a relatively short time span, the model might provide a context
with which to inform national and local health initiatives.
Buenos Aires, with its high smoking prevalence for men and
women and the highest daily cigarette use, may be in stage III of
the Lopez model. The relatively high tobacco consumption in
Buenos Aires, Argentina, a country with the highest gross
domestic product per capita of the CARMELA countries, is
consistent with trends towards increased consumption with
increased disposable income.
4 This also may be a reﬂection of
cultural differences among Buenos Aires (with a majority of
the population of European descendent) and the rest of the
participating cities. Nearly half of Santiago adults reported
smoking, and although it has a relatively low prevalence of
smokers who have attempted to quit (<40%), Santiago might be
considered early in stage III, with smoking prevalence to decline
in the years ahead. Mexico City’s smoking prevalence ﬁts within
stage II of the model, despite its high rate of smokers who have
attempted to quit and relatively low number of cigarettes
smoked per day. Barquisimeto, Bogota and Lima have approxi-
mately twice as many male smokers as female. Lung cancer
mortality in Venezuela and Colombia has been low but generally
rising since 1970 for both genders.
21 All three cities might be
considered in Lopez stage II. Quito, with its ﬁvefold difference
between male and female prevalence, conforms to stage II of the
epidemic albeit at an earlier point than the other cities. The
relatively low consumption among the women of Quito might
reﬂect Ecuador’s low gross domestic product per capita
compared to other CARMELA cities. Another plausible expla-
nation to take into consideration is the difference in cultural
factors across cities. In Ecuador, as well as other Andean coun-
tries like Peru, there are a considerable percentage of indigenous
population (non-European descendent) reﬂecting cultural
differences in patters of tobacco consumption. The classiﬁcation
of most of the CARMELA cities as stage II agrees with the
classiﬁcation of other areas of Latin America.
17 With relatively
high prevalence and unchecked increases in smoking in some
Latin American countries, the costs of tobacco-related illnesses
are likely to become a substantial economic burden.
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Figure 1 Mean (95% CI) daily consumption of cigarettes by sex and
city in participants who smoked within the month before survey.
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Research paperThe high smoking prevalence found in CARMELA cities, along
with patterns that suggest a growing tobacco epidemic, is
alarming not only for its impending impact on cardiovascular
disease but also for its augury of extensive morbidity and
mortality from other diseases,
5 22 23 That most CARMELA cities
appear to be in stage II of the Lopez descriptive model does not
necessarily mean increased morbidity and mortality in the future
as the model predicts. Morbidity from cardiovascular disease
decreases quickly after smoking cessation. After a year of absti-
nence, excess mortality from smoking decreases by half,
24 and by
3e5 years after cessation, risk of cardiovascular disease in ex-
smokers is reduced to that of non-smokers.
25 However, the data
from the CARMELA Study indicates that few smokers have tried
to quit, and overall, the number of quit attempts was limited.
Likewise,theprevalenceofhighlevelsofSHSexposureathome
andinworkplacesdemonstratedintheCARMELAStudypresents
greatchallengetolocalpolicymakers.AsofDecember22,2009,all
Latin American countries except Argentina, Cuba, Dominican
Republic and El Salvador (15 out of 19) have ratiﬁed the WHO
FCTC,
12 committing themselves to implement the most cost-
effective tobacco control policies to reduce tobacco consumption
and its health consequences. Following WHO recommendations,
four countries in the region implemented 100% smoke-free poli-
ciesatthenationallevel (Uruguayin 2006,PanamaandColombia
in 2008 and Guatemala in 2009). Argentina, Mexico and Brazil
have done so at the subnational level. Between 2002 and 2009, six
Latin American countries adopted pictorial-based health warning
labels on cigarette packages (Brazil, Uruguay, Chile, Venezuela,
Panama and Peru), and others are considering to follow suit soon
(Mexico, Bolivia and Paraguay). In 2008, Panama became the ﬁrst
country to completely ban tobacco product advertising, spon-
sorship and promotion.
CONCLUSIONS
A recurring theme in regional tobacco control efforts is the lack
of standardised data on local smoking prevalence and
consumption patterns and behaviours.
14 Using a standardised
methodology, the CARMELA Study reports high smoking
prevalence in the seven studied cities. Male smoking prevalence
ranged between that of developed and developing regions.
Female smoking prevalence was higher than previous worldwide
estimates. The highest smoking prevalence was among the
youngest two age groups, and age of initiation occurs mostly
during adolescence. In addition, substantial SHS exposure was
reported both at home and in the workplace. As a result, Latin
American urban populations will bear increasing burdens of
tobacco-induced chronic diseases. Data from the CARMELA
Study should be used wisely and vigorously to develop and
endorse effective local tobacco control policies guided by WHO
FCTC recommendations.
Limitations
Some limitations of the CARMELA study include the epidemi-
ological design (eg, cross-sectional) and the age interval of the
sample selection (eg, 25e64 years old).
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